Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy Journal Article


Authors: Krishna, C.; DiNatale, R. G.; Kuo, F.; Srivastava, R. M.; Vuong, L.; Chowell, D.; Gupta, S.; Vanderbilt, C.; Purohit, T. A.; Liu, M.; Kansler, E.; Nixon, B. G.; Chen, Y. B.; Makarov, V.; Blum, K. A.; Attalla, K.; Weng, S.; Salmans, M. L.; Golkaram, M.; Liu, L.; Zhang, S.; Vijayaraghavan, R.; Pawlowski, T.; Reuter, V.; Carlo, M. I.; Voss, M. H.; Coleman, J.; Russo, P.; Motzer, R. J.; Li, M. O.; Leslie, C. S.; Chan, T. A.; Hakimi, A. A.
Article Title: Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Abstract: Clear cell renal cell carcinomas (ccRCCs) are highly immune infiltrated, but the effect of immune heterogeneity on clinical outcome in ccRCC has not been fully characterized. Here we perform paired single-cell RNA (scRNA) and T cell receptor (TCR) sequencing of 167,283 cells from multiple tumor regions, lymph node, normal kidney, and peripheral blood of two immune checkpoint blockade (ICB)-naïve and four ICB-treated patients to map the ccRCC immune landscape. We detect extensive heterogeneity within and between patients, with enrichment of CD8A+ tissue-resident T cells in a patient responsive to ICB and tumor-associated macrophages (TAMs) in a resistant patient. A TCR trajectory framework suggests distinct T cell differentiation pathways between patients responding and resistant to ICB. Finally, scRNA-derived signatures of tissue-resident T cells and TAMs are associated with response to ICB and targeted therapies across multiple independent cohorts. Our study establishes a multimodal interrogation of the cellular programs underlying therapeutic efficacy in ccRCC. © 2021 Elsevier Inc.
Keywords: pathology; renal cell carcinoma; tyrosine kinase inhibitors; immunotherapy; tumor-associated macrophages; tissue-resident; single-cell rna-sequencing; tcr sequencing
Journal Title: Cancer Cell
Volume: 39
Issue: 5
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2021-05-10
Start Page: 662
End Page: 677.e6
Language: English
DOI: 10.1016/j.ccell.2021.03.007
PUBMED: 33861994
PROVIDER: scopus
PMCID: PMC8268947
DOI/URL:
Notes: Article -- Export Date: 1 June 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Coleman
    336 Coleman
  2. Timothy Chan
    317 Chan
  3. Paul Russo
    580 Russo
  4. Robert Motzer
    1224 Motzer
  5. Martin Henner Voss
    284 Voss
  6. Yingbei Chen
    391 Chen
  7. Christina Leslie
    186 Leslie
  8. Ming Li
    110 Li
  9. Victor Reuter
    1219 Reuter
  10. Abraham Ari Hakimi
    319 Hakimi
  11. Maria Isabel Carlo
    160 Carlo
  12. Vladimir Makarov
    57 Makarov
  13. Emily Rose Kansler
    10 Kansler
  14. Briana Glyn Nixon
    24 Nixon
  15. Ming Liu
    15 Liu
  16. Fengshen Kuo
    79 Kuo
  17. Chirag Krishna
    20 Krishna
  18. Sounak Gupta
    32 Gupta
  19. Kyle Blum
    38 Blum
  20. Lynda Vuong
    14 Vuong
  21. Kyrollis Attalla
    19 Attalla
  22. Stanley Weng
    11 Weng